Table 9.2.
• Monitoring disease status |
• Detection of micrometastases |
• Prognosis factor |
• Pharmacological studies (e.g., drug resistance) |
• Planning of personalized treatments |
• Monitoring disease status |
• Detection of micrometastases |
• Prognosis factor |
• Pharmacological studies (e.g., drug resistance) |
• Planning of personalized treatments |